Fresenius Medical Care AG

FME

DE0005785802

Healthcare Facilities & Services

Market Closed - Xetra Other stock markets 11:35:06 2024-05-17 EDT			5-day change	1st Jan Change
40.46 ^EUR	-3.02%		+0.15%	+6.59%

05-17	Moody’s Revises Outlook on Fresenius Medical Care to Stable from Negative	MT
05-16	Moody’s Affirms Fresenius' Rating, Outlook on Improving Profitability	MT

FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Jefferies remains a Sell rating

May 07, 2024 at 05:47 am

Jefferies's analyst James Vane-Tempest maintains his Sell rating on the stock. The target price continues to be set at EUR 32.

Latest news about Fresenius Medical Care AG

Moody’s Revises Outlook on Fresenius Medical Care to Stable from Negative	05-17	MT
Moody’s Affirms Fresenius' Rating, Outlook on Improving Profitability	05-16	MT
Truist Securities Adjusts Price Target on Fresenius Medical Care to $24 From $21, Maintains Hold Rating	05-15	MT
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Receives a Sell rating from Jefferies	05-14	ZD
Global markets live: Pfizer, Chevron, Amazon, Booking, Apple, Novavax, SoftBank...	05-13
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Buy rating from Berenberg	05-13	ZD
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Barclays reiterates its Neutral rating	05-13	ZD
FRESENIUS MEDCARE : adjusted target price at Barclays	05-13	CF
Fresenius Medical sees up to 2% US dialysis growth by year-end	05-11	RE
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading; End Week Up Nearly 3%	05-10	MT
Health Care Slips as Defensive Investors Rotate to Utilities - Health Care Roundup	05-08	DJ
Home REIT cuts borrowings, Genflow shares restored	05-08	AN
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Wednesday Trading	05-08	MT
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Deutsche Bank sticks Neutral	05-08	ZD
Fresenius becomes more optimistic thanks to subsidiary Kabi - exit from Vamed	05-08	DP
Dpa-AFX Overview: COMPANIES from 08.05.2024 - 15:15	05-08	DP
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Goldman Sachs maintains a Buy rating	05-08	ZD
European Midday Briefing : Stocks Buoyed by Some Solid Earnings	05-08	DJ
Fresenius makes strong start to the year - forecast raised thanks to subsidiary Kabi	05-08	DP
Fresenius Medical beats earnings expectations, keeps outlook; shares sink	05-08	RE
German healthcare group Fresenius Q1 EBIT beats expectations	05-08	RE
Strabag, Porr to Buy Portions of Fresenius' Vamed Group	05-08	MT
Fresenius Hikes FY24 Outlook	05-08	MT
EMEA Morning Briefing : Stock Futures Mixed as Earnings in Focus	05-08	DJ
FRESENIUS MEDICAL CARE : Are the 2025 targets achievable?	05-07

Chart Fresenius Medical Care AG

Duration

Period

More charts

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.

Sector

Healthcare Facilities & Services

Calendar

2024-07-29 - Q2 2024 Earnings Call

Related indices

STOXX EUROPE 600 (EUR) , MDAX

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

FRESENIUS MEDICAL CARE : Are the 2025 targets achievable?

May 07, 2024 at 04:46 pm

More Strategies

Ratings for Fresenius Medical Care AG

Trading Rating

Investor Rating

ESG Refinitiv

A-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

40.46 EUR

Average target price

39.48 EUR

Spread / Average Target

-2.42%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
FRESENIUS MEDICAL CARE AG	+6.59%	12.91B
HCA HEALTHCARE, INC.	+19.28%	84.56B
CVS HEALTH CORPORATION	-26.95%	72.41B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+4.58%	27.75B
LABORATORY CORPORATION OF AMERICA HOLDINGS	-7.35%	17.75B
FRESENIUS SE & CO. KGAA	-0.46%	17.11B
QUEST DIAGNOSTICS INCORPORATED	+4.69%	16.03B
REDE D'OR SÃO LUIZ S.A.	+8.14%	13.72B
NATERA, INC.	+69.96%	13.07B
TENET HEALTHCARE CORPORATION	+70.00%	12.55B

Other Healthcare Facilities & Services

Fresenius Medical Care AG

Equities

FME

DE0005785802

Healthcare Facilities & Services

FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Jefferies remains a Sell rating

EPS Revisions